TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis

Area of Science:

• Genetics
• Oncology
• Molecular Epidemiology

Background:

• The TP53 Arg72Pro polymorphism is a common genetic variation.
• Previous studies on its association with endometrial cancer risk have yielded inconsistent findings.
• Clarifying this relationship is crucial for understanding endometrial carcinogenesis.

Purpose of the Study:

• To conduct a meta-analysis to precisely estimate the association between the TP53 Arg72Pro polymorphism and endometrial cancer risk.
• To investigate potential sources of heterogeneity in previous study results.

Main Methods:

• A systematic literature search was performed in PubMed to identify relevant case-control studies.
• Data from 8 studies (2,154 subjects) were analyzed using various genetic models (codominant, dominant, recessive).
• Subgroup analyses were conducted based on factors like Hardy-Weinberg equilibrium, specimen type, sample size, control source, and ethnicity.

Main Results:

• Overall meta-analysis revealed no statistically significant association between TP53 Arg72Pro genotypes and endometrial cancer risk across all genetic models.
• Stratified analyses also showed no significant associations, except in a subgroup where controls deviated from Hardy-Weinberg equilibrium in the recessive model.
• This exception (OR=1.60, 95% CI: 1.07-2.39) warrants cautious interpretation.

Conclusions:

• The TP53 Arg72Pro polymorphism does not appear to play a significant role in endometrial cancer development.
• Discrepancies in prior research may be attributed to methodological limitations, including bias and small sample sizes.
• Further research with robust methodologies is needed to confirm these findings.